1 of 10next Page
Financial Statements

Bayer Group Consolidated Income Statements

   [Table 22]
 2nd Quarter 20142nd Quarter 20151st Half 20141st Half 2015
 € million€ million€ million€ million
Net sales10,22812,09020,58023,969
Cost of goods sold(4,991)(5,312)(9,725)(10,788)
Gross profit5,2376,77810,85513,181
     
Selling expenses(2,552)(3,177)(4,920)(6,097)
Research and development expenses(841)(1,036)(1,653)(1,982)
General administration expenses(427)(550)(835)(1,021)
Other operating income8031208278
Other operating expenses(62)(213)(155)(582)
EBIT11,4351,8333,5003,777
     
Equity-method loss(3)(6)(8)
Financial income988519097
Financial expenses(268)(366)(514)(658)
Financial result(173)(287)(332)(561)
     
Income before income taxes1,2621,5463,1683,216
     
Income taxes(343)(405)(851)(811)
     
Income from continuing operations after income taxes9191,1412,3172,405
     
Income from discontinued operations after income taxes36176362
     
Income after income taxes9551,1582,3802,467
of which attributable to non-controlling interest26412
of which attributable to Bayer AG stockholders (net income)9531,1522,3762,455
     
 
Earnings per share    
From continuing operations    
Basic1.111.372.802.89
Diluted1.111.372.802.89
     
From discontinued operations    
Basic0.040.020.070.08
Diluted0.040.020.070.08
     
From continuing and discontinued operations    
Basic1.151.392.872.97
Diluted1.151.392.872.97
1 EBIT = earnings before financial result and taxes
2014 figures restated
1 of 10next Page
Last updated: July 29, 2015  Copyright © Bayer AG
http://www.quarterly-report-2015-q2.bayer.com